Most recently, it's been recognized that conolidine and the above mentioned derivatives act on the atypical chemokine receptor three (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to some wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts as a scavenger https://dicks428fjp4.csublogs.com/profile